Company news

Syros Pharmaceuticals, Inc. (OTC:SYRS) news

Syros Pharmaceuticals, Inc. news releases on 6ix. Latest, Jul 16, 2025: Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50…

View Syros Pharmaceuticals, Inc. →

Press releases & updates

Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital

July 16, 2025

Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration

February 28, 2025